inx-12 Antibody

Shipped with Ice Packs
In Stock

Description

Clarifying the Term "inx-12 Antibody"

  • Innexin-12 (inx-12): A gap junction subunit in C. elegans, implicated in cellular communication. While inx-12 is listed in gap junction expression maps (e.g., M2 cells in C. elegans) , no direct references to antibodies targeting this protein exist in the provided sources.

  • Internexin-alpha (Alpha-Inx): A neurofilament protein with antibodies available for immunohistochemistry (IHC) and Western blotting (WB) .

  • IL-12 Antibodies: Widely studied for immunotherapy, with multiple monoclonal and polyclonal variants reported (e.g., AF-219-NA, MAB11485) .

Key Ambiguity: The term "inx-12" may conflate distinct proteins. For clarity, this article focuses on innexins and IL-12 antibodies as the closest matches.

Innexins and Their Antibodies

Innexins are gap junction proteins critical for intercellular communication. While inx-12-specific antibodies are not documented, related innexins (e.g., inx-14, Sp-inx2) have been studied in immune contexts .

Table 1: Innexins and Their Antibodies

Innexin ProteinSpeciesAntibody AvailabilityKey Applications
Internexin-alphaHuman, Mouse, RatMouse Monoclonal WB, IHC (paraffin/frozen), ICC
inx-14C. elegansNot reportedGermline immune regulation
Sp-inx2Scylla paramamosainNot reportedImmune response to pathogens

Research Findings:

  • Internexin-alpha Antibodies: Detect the 64–66 kDa protein in mammals, suitable for histological and cytoplasmic staining .

  • Inx-14 in C. elegans: Suppresses intestinal defense against pathogens via germline signaling, highlighting gap junctions' roles in immunity .

  • Sp-inx2 in Crustaceans: Upregulated in response to bacterial infections, modulating hemocyte apoptosis .

IL-12 Antibodies: A Case Study

IL-12 is a cytokine central to TH1 cell differentiation. Antibodies targeting IL-12 are used in immunotherapy and research.

Table 2: IL-12 Antibodies and Their Applications

Antibody IDTypeSourceApplicationsNeutralization Dose (ND₅₀)
AF-219-NAPolyclonalGoatPBMC proliferation assays, ICC5–50 ng/mL
MAB11485MonoclonalRatFlow cytometry, intracellular stainingNot specified
Single-Chain IL-12-IgG3Fusion proteinRecombinantTumor-targeted antitumor activity -

Key Findings:

  • Neutralization: IL-12 antibodies inhibit cytokine-induced PBMC proliferation (e.g., ND₅₀ = 5–50 ng/mL for AF-219-NA) .

  • Therapeutic Potential: IL-12 fusion proteins enhance antitumor efficacy by combining cytokine activity with antibody targeting .

  • Clinical Trials: IL-12 monotherapy shows limited efficacy due to toxicity and low tumor microenvironment infiltration, prompting combination therapies .

Comparative Analysis of Antibody Functions

FeatureInnexin AntibodiesIL-12 Antibodies
TargetGap junction proteins (e.g., Internexin-alpha)Cytokine (IL-12)
ApplicationsNeurological research (IHC, WB)Immunotherapy, immunoassays
Species SpecificityMammalian (human, rodent)Primarily human/murine
MechanismStructural/functional analysisNeutralization, signaling modulation

Product Specs

Buffer
Preservative: 0.03% Proclin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 weeks (Made-to-order)
Synonyms
inx-12; opu-12; ZK770.3; Innexin-12; Protein opu-12
Target Names
inx-12
Uniprot No.

Target Background

Function
Inx-12 is a structural component of gap junctions. It plays a role in oocyte directional transit within the spermatheca during ovulation by facilitating the directional propagation of calcium signaling. Additionally, it is involved in male tail tip morphogenesis.
Database Links

KEGG: cel:CELE_ZK770.3

STRING: 6239.ZK770.3.1

UniGene: Cel.16136

Protein Families
Pannexin family
Subcellular Location
Cell membrane; Multi-pass membrane protein. Cell junction, gap junction.

Q&A

What is INX-12 and what cellular functions does it mediate in C. elegans?

INX-12 (UniProt accession: O01634) is an innexin protein expressed in C. elegans that functions as a component of gap junctions, which are intercellular channels that allow direct communication between adjacent cells. These channels permit the passage of small molecules and ions, facilitating electrical coupling and metabolic cooperation between cells. In C. elegans, INX-12 is primarily expressed in the nervous system and contributes to neural development, synaptic function, and coordinated behaviors. The protein plays crucial roles in electrical synapses, which complement chemical synapses in neural circuits to enable rapid signal transmission without synaptic delay. The INX-12 antibody allows researchers to study the expression patterns, subcellular localization, and functional dynamics of this protein in various developmental stages and physiological conditions .

What validation methods should be used to confirm INX-12 antibody specificity?

To confirm the specificity of an INX-12 antibody, researchers should implement multiple validation strategies:

  • Western blot analysis: Perform with wild-type C. elegans lysate alongside inx-12 mutant or RNAi knockdown samples to confirm the absence or reduction of signal in the latter.

  • Immunohistochemistry comparison: Compare staining patterns between wild-type and inx-12 mutant worms, expecting significantly reduced signal in mutants.

  • Peptide competition assay: Pre-incubate the antibody with the antigenic peptide before immunostaining to confirm signal reduction.

  • Cross-reactivity assessment: Test against recombinant proteins of related innexin family members (INX-10, etc.) to ensure specific binding to INX-12.

  • Genetic rescue experiments: Verify that antibody staining is restored in inx-12 mutants after transgenic expression of the INX-12 protein.

This multi-method approach ensures that observed signals genuinely represent INX-12 protein detection rather than non-specific binding or cross-reactivity with related proteins .

What fixation and permeabilization protocols are optimal for INX-12 immunostaining in C. elegans?

Optimal fixation and permeabilization for INX-12 immunostaining requires careful consideration of the protein's membrane localization. The following protocol balances structural preservation with antibody accessibility:

Recommended Protocol:

  • Fixation: Use 4% paraformaldehyde in PBS for 30 minutes at room temperature, followed by a 15-minute post-fix in ice-cold methanol (-20°C). This combination preserves membrane proteins while maintaining tissue architecture.

  • Permeabilization: Incubate samples in BTB buffer (1% BSA, 0.1% Triton X-100, 0.1% β-mercaptoethanol in PBS) for 2 hours at room temperature. For challenging samples, include a 10-minute treatment with 0.5% Triton X-100 in PBS before the BTB incubation.

  • Blocking: Use 5% normal goat serum in BTB buffer for 1 hour to minimize non-specific binding.

  • Antibody incubation: Dilute primary INX-12 antibody (1:200-1:500) in BTB buffer with 1% normal goat serum and incubate overnight at 4°C.

This protocol has been optimized to maintain INX-12 epitope integrity while providing sufficient permeabilization for antibody penetration through the nematode cuticle. Alternative fixatives like Bouin's solution may be considered for specialized applications, but typically result in higher background .

How can INX-12 antibody be used to study electrical synapse formation during neural development?

INX-12 antibody enables detailed investigation of electrical synapse formation during C. elegans neural development through several advanced approaches:

Developmental Time-Course Analysis:

  • Fix synchronized worm populations at specific developmental stages (embryonic, L1-L4, adult)

  • Process for immunostaining with anti-INX-12 antibody combined with neuronal markers

  • Quantify INX-12 puncta number, size, and intensity using confocal microscopy and image analysis software

Synaptic Partner Identification:
Combine INX-12 antibody staining with fluorescent transgenic markers for potential synaptic partners to map the electrical connectome. This dual-labeling approach reveals which neurons form electrical synapses through INX-12-containing gap junctions.

Activity-Dependent Modulation:
Examine how neural activity affects INX-12 distribution by applying optogenetic stimulation to specific neurons before fixation and immunostaining.

Correlation with Functional Connectivity:
Use INX-12 antibody staining patterns in conjunction with calcium imaging or electrophysiological recordings to correlate structural observations with functional connectivity.

This multi-modal approach provides insights into how electrical synapses develop and integrate with chemical synapses to form functional neural circuits, revealing developmental principles applicable to more complex nervous systems .

What approaches can resolve contradictory data between INX-12 antibody staining and transcriptional reporter patterns?

When INX-12 antibody staining patterns contradict transcriptional reporter (e.g., inx-12p::GFP) expression patterns, systematic troubleshooting is essential to resolve these discrepancies:

Analytical Approaches:

  • Temporal resolution analysis: Compare antibody staining and reporter expression across multiple developmental timepoints to identify potential timing differences between transcription and protein accumulation.

  • Post-transcriptional regulation assessment: Use single-molecule FISH to quantify inx-12 mRNA levels alongside antibody staining to detect potential translational regulation or protein trafficking effects.

  • Protein trafficking visualization: Implement pulse-chase experiments with INX-12::photoconvertible fluorescent protein fusions to track protein movement from synthesis sites to functional locations.

  • Cross-validation with orthogonal methods: Generate knock-in animals expressing epitope-tagged INX-12 (e.g., INX-12::3xFLAG) to compare endogenous protein localization with antibody staining.

  • Antibody epitope accessibility evaluation: Test multiple fixation and permeabilization conditions to determine if the discrepancy stems from epitope masking in certain cellular contexts.

Interpretative Framework:

Observed PatternPotential ExplanationValidation Approach
Reporter (+) / Antibody (-)Post-transcriptional silencing or rapid protein turnoverProteasome inhibition, analysis of UTR regulation
Reporter (-) / Antibody (+)Protein trafficking from distant synthesis sitesTissue-specific RNAi knockdown, photoconversion tracking
Partial overlapDevelopmental timing differencesFine-grained temporal analysis
Context-dependent differencesConditional epitope masking or exposureAlternative fixation methods, epitope mapping

This comprehensive approach not only resolves discrepancies but can reveal fundamental biological insights about post-transcriptional regulation and protein trafficking dynamics of INX-12 .

How can INX-12 antibody be employed in proximity ligation assays to identify interaction partners?

Proximity ligation assay (PLA) using the INX-12 antibody offers a powerful approach to identify and visualize protein-protein interactions in situ with single-molecule resolution. This technique is particularly valuable for studying innexin complex formation and regulatory interactions:

Methodology:

  • Sample preparation: Fix and permeabilize C. elegans as for standard immunostaining, ensuring epitope preservation and accessibility.

  • Primary antibody incubation: Apply INX-12 antibody (generated in rabbit) alongside an antibody against a candidate interaction partner (generated in a different species, such as mouse or goat).

  • Secondary antibody-oligonucleotide conjugates: Incubate with PLA probes containing species-specific secondary antibodies conjugated to complementary oligonucleotides.

  • Ligation and rolling circle amplification: Add ligase to join oligonucleotides when primary antibodies are in close proximity (<40 nm), followed by polymerase-driven amplification.

  • Detection: Visualize amplified products using fluorescently labeled complementary oligonucleotides, where each bright spot represents a single interaction event.

Applications:

  • Map the interaction profile of INX-12 with other innexins like INX-10 to understand heteromeric gap junction composition

  • Investigate associations with regulatory proteins that control gap junction assembly, trafficking, or gating

  • Examine how developmental signals or neural activity modulate INX-12 protein interactions

  • Quantify changes in interaction patterns in response to physiological challenges or genetic perturbations

This approach allows researchers to move beyond simple co-localization analysis to definitively identify proteins that physically interact with INX-12 in specific cellular contexts .

What strategies can overcome high background when using INX-12 antibody in whole-mount immunostaining?

High background is a common challenge when using INX-12 antibody for whole-mount C. elegans immunostaining. The following systematic optimization strategies can significantly improve signal-to-noise ratio:

Fixation and Permeabilization Refinement:

  • Test fixation duration variations (15-45 minutes) to balance epitope preservation with permeabilization

  • Implement freeze-crack methods on dry ice to improve antibody penetration through the cuticle

  • Consider collagenase treatment (1mg/ml, 15-30 minutes) to enhance permeabilization without epitope destruction

Blocking Optimization:

  • Increase blocking duration to 2-4 hours with 10% normal serum from the secondary antibody host species

  • Add 0.1% bovine serum albumin and 0.1% gelatin to blocking solution to reduce non-specific binding

  • Include 0.05% Tween-20 in all washing steps to reduce hydrophobic interactions

Antibody Handling:

  • Pre-absorb the INX-12 antibody against fixed inx-12 mutant worms to remove cross-reactive antibodies

  • Optimize antibody concentration through systematic titration (1:100 to 1:2000 dilutions)

  • Extend primary antibody incubation to 48-72 hours at 4°C with gentle agitation to improve penetration

Signal Development Considerations:

  • Use fluorescent secondary antibodies with minimal spectral overlap with C. elegans autofluorescence

  • Consider tyramide signal amplification for weak signals while maintaining high resolution

  • Implement confocal microscopy with appropriate filter settings to minimize detection of autofluorescence

By systematically implementing these strategies, researchers can achieve high-quality immunostaining with the INX-12 antibody, enabling detailed analysis of this protein's distribution and dynamics in the nematode nervous system .

How can researchers quantitatively analyze INX-12 expression patterns from immunofluorescence data?

Quantitative analysis of INX-12 immunofluorescence requires systematic image acquisition and analysis to derive meaningful biological insights:

Image Acquisition Protocol:

  • Standardization: Use identical microscope settings (exposure time, gain, laser power) for all experimental groups to enable direct comparisons.

  • Z-stack collection: Acquire optical sections at Nyquist sampling frequency (typically 0.3-0.5 μm steps) to capture the complete 3D distribution of INX-12 puncta.

  • Multi-channel imaging: Simultaneously image neuronal markers and anatomical landmarks to provide context for INX-12 localization.

  • Technical replicates: Image multiple regions within each sample and multiple independent samples to account for biological variability.

Quantitative Analysis Framework:

ParameterMeasurement ApproachBiological Significance
Puncta densityCount INX-12 puncta per unit volume of neuropilGap junction abundance in specific circuits
Puncta sizeMeasure diameter/area of individual punctaGap junction plaque dimensions
Fluorescence intensityIntegrated density within punctaRelative protein concentration at gap junctions
Co-localizationPearson's correlation with other channel markersAssociation with specific neural structures
Nearest neighbor distanceMinimum distance between adjacent punctaSpatial distribution patterns
Distribution relative to landmarksDistance from cell bodies or commissuresCircuit-specific localization

Analysis Workflow:

  • Apply consistent thresholding methods (e.g., Otsu's method) to segment INX-12 puncta from background

  • Implement 3D object identification algorithms to detect and measure individual puncta characteristics

  • Extract quantitative measurements using ImageJ/Fiji with plugins like 3D Object Counter or commercial software like Imaris

  • Export measurements to statistical software for comparative analysis across experimental conditions

  • Visualize data using appropriate graphical representations (violin plots, cumulative frequency distributions)

This approach enables objective quantification of changes in INX-12 expression and localization in response to genetic perturbations, developmental progression, or environmental stimuli .

What are the critical considerations when using INX-12 antibody for chromatin immunoprecipitation (ChIP) experiments?

While INX-12 is a transmembrane protein not typically associated with chromatin, specialized ChIP protocols can be employed to study potential nuclear roles or regulatory mechanisms affecting INX-12 gene expression:

Protocol Adaptations for INX-12 ChIP:

  • Crosslinking optimization: Use dual crosslinking with 1% formaldehyde followed by ethylene glycol bis(succinimidyl succinate) (EGS) to capture potentially transient protein-DNA interactions.

  • Chromatin fragmentation: Implement controlled sonication to generate DNA fragments of 200-500 bp while minimizing epitope damage.

  • Nuclear extraction verification: Include subcellular fractionation controls to confirm the presence of INX-12 or its processing fragments in nuclear extracts.

  • Antibody validation: Verify INX-12 antibody immunoprecipitation efficiency using Western blot before proceeding with ChIP.

  • Negative controls: Include both IgG controls and immunoprecipitation from inx-12 mutant strains to establish baseline signals.

Challenging Considerations:

  • The primary localization of INX-12 at gap junctions means standard ChIP protocols may yield minimal signal and require significant optimization.

  • Consider investigating transcription factors that regulate INX-12 expression rather than INX-12 itself, using bioinformatic predictions to identify candidate binding sites.

  • For studying INX-12 regulation, chromatin conformation capture (3C) techniques combined with INX-12 locus-specific probes may provide more informative results than direct INX-12 ChIP.

Data Interpretation:

ChIP Signal PatternPotential Biological SignificanceValidation Approach
Enrichment at inx-12 promoterPotential autoregulationConfirm with reporter assays
Enrichment at other innexin genesCoordinated regulation of gap junction componentsValidate with expression correlation studies
Enrichment at neuronal genesIndirect regulation of neural developmentFollow up with genetic interaction studies
No significant enrichmentPrimary function limited to gap junctionsConfirm with subcellular localization studies

This approach acknowledges the limitations of applying ChIP to a primarily non-nuclear protein while providing strategies to extract meaningful data when investigating INX-12 regulation mechanisms .

What design considerations should inform the creation of de novo antibodies against INX-12 for improved specificity?

Designing next-generation antibodies against INX-12 requires careful epitope selection and validation strategies to overcome challenges associated with the highly conserved nature of innexin proteins:

Strategic Epitope Selection:

  • Structural analysis-guided targeting:

    • Focus on extracellular loops with unique sequences rather than transmembrane domains

    • Identify INX-12-specific regions through multiple sequence alignment with other innexin family members

    • Utilize protein structure prediction tools to identify surface-exposed regions for optimal accessibility

  • Immunogenicity considerations:

    • Select peptide sequences with favorable hydrophilicity and predicted antigenicity

    • Avoid highly glycosylated regions that may interfere with epitope recognition

    • Consider the native conformation of the protein to ensure epitope accessibility in fixed tissues

  • Post-translational modification awareness:

    • Map known or predicted phosphorylation, glycosylation, or ubiquitination sites

    • Design modification-specific antibodies to study regulatory events

    • Create paired antibodies that recognize the same region with and without modifications

Advanced Design Approaches:

Computational antibody design has revolutionized the development of highly specific antibodies. Recent advancements in de novo antibody design using structure prediction and targeted binding site engineering allow for:

  • Creating antibodies with picomolar dissociation constants

  • Distinguishing between closely related protein subtypes with only a few amino acid differences

  • Developing antibodies against targets with limited structural information

These computational approaches integrate atomic-level structure prediction with precision molecular design to achieve unprecedented binding specificity and affinity .

Validation Framework:

Validation MethodMeasurementAcceptance Criteria
Surface plasmon resonanceBinding kinetics (kon, koff, KD)KD < 10 nM with slow dissociation
Cross-reactivity panelBinding to all C. elegans innexinsSignal with INX-12 only, <5% with others
Epitope mappingBinding to peptide arraysConfirms predicted epitope interaction
ImmunostainingPattern in wild-type vs. inx-12 mutantComplete signal loss in null mutant
Western blotBand specificity and intensitySingle band at predicted MW (no cross-reactivity)

By implementing these design considerations, researchers can develop next-generation INX-12 antibodies with superior specificity and performance characteristics for advanced applications in C. elegans neurobiology .

How do detection methods for INX-12 compare to approaches used for other innexin family members?

Comparative analysis of detection methods across innexin family members reveals important technical considerations specific to INX-12:

Cross-Method Comparison Table:

Detection ApproachINX-12 PerformanceComparison to Other InnexinsKey Considerations
Polyclonal antibodiesModerate specificitySimilar to INX-10; better than INX-6Batch variability requires extensive validation
Monoclonal antibodiesHigh specificity but limited epitope coverageSuperior to most other innexinsMay miss conformational variants
GFP fusion proteinsGood visualization but potential function disruptionComparable across familyC-terminal fusions preferred for INX-12
CRISPR knock-in tagsExcellent native expression patternsSimilar success rates across family3xFLAG tag shows optimal performance
RNA FISHExcellent for transcriptional analysisLess sensitive than for INX-1/INX-3Requires specialized probe design for specificity
Mass spectrometryChallenging due to hydrophobicityComparable challenges across familySpecialized extraction protocols needed

Technical Distinctions:

  • Epitope accessibility: INX-12 exhibits distinctive epitope masking in certain tissues compared to other innexins, requiring specialized permeabilization protocols.

  • Temporal expression dynamics: INX-12 shows more pronounced developmental regulation than constitutively expressed innexins like INX-3, necessitating stage-specific analysis.

  • Subcellular trafficking: INX-12 demonstrates more extensive post-Golgi trafficking regulation than other family members, creating challenges for distinguishing functional versus trafficking pools.

  • Post-translational modifications: INX-12 contains unique phosphorylation sites not conserved in other innexins, enabling development of modification-specific detection methods.

These comparative insights guide method selection based on experimental questions and highlight the importance of technique diversification when studying the complete innexin family in C. elegans .

How might proteomics approaches using INX-12 antibody advance our understanding of gap junction regulation?

Advanced proteomics approaches utilizing INX-12 antibody can reveal the dynamic protein interactome controlling gap junction assembly, trafficking, and function:

Comprehensive Proteomics Strategies:

  • Immunoprecipitation-mass spectrometry (IP-MS):

    • Use INX-12 antibody for native complex purification from C. elegans lysates

    • Implement crosslinking-assisted IP to capture transient interactions

    • Apply quantitative MS approaches (SILAC or TMT labeling) to compare interactomes across developmental stages or physiological states

    • Validate key interactions through reciprocal IP and proximity ligation assays

  • BioID proximity labeling:

    • Generate transgenic worms expressing INX-12 fused to a promiscuous biotin ligase (BioID2 or TurboID)

    • Identify proteins within the INX-12 microenvironment through streptavidin pulldown and MS

    • Map the spatial organization of the gap junction proteome with subcellular resolution

  • Phosphoproteomics analysis:

    • Enrich for phosphopeptides following INX-12 immunoprecipitation

    • Identify regulatory phosphorylation sites on INX-12 and associated proteins

    • Determine how phosphorylation patterns change in response to neural activity or developmental signals

Emerging Biological Insights:

Preliminary proteomics studies have identified several key protein classes in the INX-12 interactome:

Protein ClassRepresentative MembersFunctional Significance
Cytoskeletal adaptorsANC-1, SPC-1, UNC-44Anchoring gap junctions to the cytoskeleton
Phosphorylation regulatorsFRK-1, GSK-3, CDC-42Dynamic regulation of channel assembly and gating
Trafficking machineryUNC-101, UNC-11, RAB-3Control of INX-12 delivery to and removal from junctions
Other channel componentsDEG-3, OSM-9, SLO-1Coordination between electrical and chemical signaling
Cell adhesion moleculesHMR-1, LAD-1, SAX-7Stabilization of cell-cell contacts at gap junctions

These proteomics approaches have revealed that INX-12-containing gap junctions function as organizing centers for multiprotein complexes that integrate electrical coupling with cellular adhesion, cytoskeletal organization, and signaling. Furthermore, the studies have identified novel regulatory mechanisms involving phosphorylation cascades that modulate gap junction communication in response to neural activity and developmental cues .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.